AU4513393A - Pharmaceutical composition containing antiulcer agent - Google Patents

Pharmaceutical composition containing antiulcer agent

Info

Publication number
AU4513393A
AU4513393A AU45133/93A AU4513393A AU4513393A AU 4513393 A AU4513393 A AU 4513393A AU 45133/93 A AU45133/93 A AU 45133/93A AU 4513393 A AU4513393 A AU 4513393A AU 4513393 A AU4513393 A AU 4513393A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
composition containing
antiulcer agent
antiulcer
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45133/93A
Inventor
Kuniki Ikeda
Naohiro Oishi
Toshiyuki Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU4513393A publication Critical patent/AU4513393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU45133/93A 1992-07-17 1993-07-02 Pharmaceutical composition containing antiulcer agent Abandoned AU4513393A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP21343692 1992-07-17
JP14302893 1993-05-20
JP5-143028 1993-05-20
JP4-213436 1993-05-20
PCT/JP1993/000920 WO1994002140A1 (en) 1992-07-17 1993-07-02 Pharmaceutical composition containing antiulcer agent

Publications (1)

Publication Number Publication Date
AU4513393A true AU4513393A (en) 1994-02-14

Family

ID=26474849

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45133/93A Abandoned AU4513393A (en) 1992-07-17 1993-07-02 Pharmaceutical composition containing antiulcer agent

Country Status (2)

Country Link
AU (1) AU4513393A (en)
WO (1) WO1994002140A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094694B1 (en) * 1995-02-01 1997-12-16 Esteve Quimica Sa NEW PHARMACEUTICALLY STABLE FORMULATION OF A COMPOUND OF BENZMIDAZOLE AND ITS PROCESS OF OBTAINING.
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
DE19626045C2 (en) * 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab A stable dosage form for oral administration containing omeprazole as the active ingredient and methods of making the same
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
AU731186B2 (en) * 1997-03-13 2001-03-29 Hexal Ag Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
SI9700186B (en) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Novel pharmaceutical preparation with controlled release of active healing substances
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
DK173431B1 (en) 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Pharmaceutical formulation comprising a 2 - [[(2-pyridinyl) methyl] sulfinyl] benzimidazole with anti-ulcer activity and progress
CA2340054C (en) 1998-08-12 2005-10-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
GB9923436D0 (en) * 1999-10-04 1999-12-08 American Home Prod Pharmaceutical compositions
CA2398555C (en) * 2000-01-27 2008-04-22 Tanabe Seiyaku Co., Ltd. Sustained release preparation and method for producing the same
JP4902928B2 (en) * 2000-05-24 2012-03-21 大塚製薬株式会社 Formulation stabilization method
ATE508725T1 (en) * 2001-06-20 2011-05-15 Takeda Pharmaceutical METHOD FOR PRODUCING TABLETS
SG103334A1 (en) * 2002-01-24 2004-04-29 Il Yang Pharm Co Ltd Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
WO2005046634A2 (en) * 2003-11-14 2005-05-26 Siegfried Generics International Ag Gastric juice-resistant form of administration
HU227317B1 (en) * 2003-11-25 2011-03-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Enteric coated tablet containing pantoprazole
MXPA06009991A (en) * 2004-03-03 2007-04-10 Teva Pharma A stable pharmaceutical composition comprising an acid labile drug.
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2009113090A2 (en) * 2008-01-17 2009-09-17 Alkem Laboratories Ltd. Process for preparing an oral formulation of an acid-sensitive benzimidazole drug
CN113384547B (en) * 2021-06-25 2024-03-19 上海信谊万象药业股份有限公司 Omeprazole aluminum magnesium carbonate composite tablet and preparation process thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
AU619444B2 (en) * 1986-06-02 1992-01-30 Nippon Chemiphar Co. Ltd. 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
ES2024993A6 (en) * 1990-12-31 1992-03-01 Genesis Para La Investigacion Procedure for obtaining an oral pharmaceutical preparation containing omeprazole

Also Published As

Publication number Publication date
WO1994002140A1 (en) 1994-02-03

Similar Documents

Publication Publication Date Title
AU4513393A (en) Pharmaceutical composition containing antiulcer agent
AU1629297A (en) Pharmaceutical composition containing botulinum B complex
AU3373293A (en) Anthraquinone compounds and pharmaceutical compositions containing them
AU3716193A (en) Pharmaceutical compositions
AU6418596A (en) Compounds and pharmaceutical compositions containing them
GB9319500D0 (en) Pharmaceutical composition
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
AU3542993A (en) Pharmaceutical compounds
AU1189392A (en) Pharmaceutical agent
AU2392492A (en) Pharmaceutical composition
ZA937592B (en) Pharmaceutical composition
AU5220893A (en) Substituted N-hydroxycinnamamides, processes for their preparation, compositions containing them, and their use
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
ZA94155B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
AU2876889A (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
AU7135091A (en) Pharmaceutical composition
AU3528593A (en) Pharmaceutical composition
RU2003257C1 (en) Phytotea composition
ZA924061B (en) Pharmaceutical composition
ZA935931B (en) Pharmaceutical composition
AU3101593A (en) New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it
AU673835C (en) Medicinal composition comprising TCF-II